PRMT1 also regulates EMT in breast cancer cells while CARM1/PRMT4 promotes breast cancer metastasis by methylating arginine residue R1064 of BAF155, a chromatin remodeling factor [1,99]. Here, SMARCC1 is linked to breast carcinoma.